<DOC>
	<DOCNO>NCT01280825</DOCNO>
	<brief_summary>The purpose study collect DNA sample patient undergo routine care University Chicago . These sample test difference gene may suggest great risk side effect chance increase benefit certain medication . The result make available patient 's treat physician researcher track whether information use routine health care .</brief_summary>
	<brief_title>The 1200 Patients Project : Studying Implementation Clinical Pharmacogenomic Testing</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Autoimmune Diseases</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Receiving ongoing , outpatient care University Chicago Medical Center routine care physician participate trial Life expectancy least 3 year Must 18 year old Must take least 1 ( 6 ) prescription medication time enrollment OR 65 year old OR reasonably expect require use prescription medication within next 5 year Patients certain disease , likely receive receive certain drug , target particularly enrollment order enrich study patient likely pharmacogenetically relevant interaction , include , limited : Patients require specialized cardiology care Patients inflammatory bowel diseases Patients systemic autoimmune inflammatory diseases Patients require longterm oral anticoagulation Patients hepatitis C Patients nonmetastatic cancer Patients acute chronic disease could reasonably expect result patient 's death within next 3 year . Patients undergone , actively consider , liver kidney transplantation . Inability understand give inform consent participate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>